Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase …
Oct 11, 2024
finanznachrichten.de
Scholar Rock Files US FDA Application for Apitegromab in Spinal Muscular Atrophy
Scholar Rock Files US FDA Application for Apitegromab in Spi…
Jan 29, 2025
marketscreener.com
Apitegromab for the treatment of SMA
2:49
Apitegromab for the treatment of SMA
991 viewsJul 6, 2021
YouTubeVJNeurology
High Dose Nusinersen, Apitegromab Receive CRLs, Tolebrutinib PDUFA Pushed Back | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
High Dose Nusinersen, Apitegromab Receive CRLs, Tolebrutinib PDUF…
6 months ago
neurologylive.com
L'étude Scholar Rock sur un traitement potentiel de l'amyotrophie spinale atteint ses objectifs secondaires
L'étude Scholar Rock sur un traitement potentiel de l'amyotrop…
Mar 17, 2025
zonebourse.com
A breakthrough in the treatment of spinal muscular atrophy
1:18
A breakthrough in the treatment of spinal muscular atrophy
150 viewsMay 20, 2024
YouTubeAkronChildrens
FSHD GLOBAL🌏 on Instagram: "FSHD Global welcomes the recent update from Scholar Rock who have outlined their plans to commence a Phase 2 clinical study of Apitegromab for FSHD in mid-2026, following clearance of an Investigational New Drug (IND) application. The study, referred to as FORGE, is designed as a randomised, double-blind, placebo-controlled Phase 2 trial. Apitegromab is a muscle-targeted therapy that is also in late-stage clinical development for spinal muscular atrophy (SMA). The FO
FSHD GLOBAL🌏 on Instagram: "FSHD Global welcomes the recen…
2 months ago
Instagramfshdglobal
1:58
Understanding Spinal Muscular Atrophy (SMA)
180.8K viewsJul 24, 2020
YouTubeGenentech
1:04
艾曲泊帕/艾曲波帕Eltrombopag的药理作用【医游记】
Nov 30, 2023
sohu医游记小美
Scholar Rock : la FDA émet une lettre de réponse complète pour l…
6 months ago
zonebourse.com
1:03
FDA Halts SMA Drug: HUGE News for Apitegromab! #shorts
132 views6 months ago
YouTubeNeuromuscular Medicine Expert
4:51
Biotech FDA Decisions September 2025 | PDUFA Calendar & Outlook
186 views6 months ago
YouTubeShareTreck
Switching ITP Patients to Avatrombopag From Other TPO-R…
241 viewsAug 30, 2024
vumedi.com
9:48
Scholar Rock - New Data on Investigational Muscle-Targeted S…
675 viewsSep 7, 2023
YouTubeHPR
7:03
美股医疗股新机会
35 views7 months ago
bilibiliRealFreeman
1:19:29
Move Aside Ozempic, Apitegromab is Here (Soon)
15 views4 months ago
YouTube1% Better - Hidden Stories in Sport Podcast
Positioning Emerging B-Cell Modulators in Future IgAN Treatm…
2 months ago
hcplive.com
8:57
[FullVer] Scholar Rock Mystery | Why Did FDA Halt a Perfect Drug …
49 views5 months ago
YouTube불로불사 프로젝트
3:00
Scholar Rock Mystery | Why Did FDA Halt a Perfect Drug Approval…
177 views5 months ago
YouTube메타 유니버스
59:36
Watch: Aprub - November 06, 2018
75 viewsNov 6, 2018
YouTubeNET25 News and Information
0:49
Dr. Fertrin on the FDA Approval of Avatrombopag in ITP
376 viewsJul 2, 2019
YouTubeOncLive
1:24
阿伐曲泊帕（Avatrombopag）——血小板减少症克星【医游记】
67 viewsOct 30, 2023
bilibili医游记
0:58
Big FDA Calls This Month | PDUFA Outlook October 2025
566 views6 months ago
YouTubeShareTreck
1:10
Avatrombopag following switch from eltrombopag or romiplostim i…
1.7K viewsJul 14, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:14
阿伐曲泊帕（Avatrombopag）副作用有哪些？【医游记】
48 viewsOct 30, 2023
bilibili医游记
59:01
Watch: Aprub - November 27, 2018
88 viewsNov 27, 2018
YouTubeNET25 News and Information
3:50
Aptiom Shows Strong Results as Epilepsy Monotherapy
2.5K viewsApr 21, 2015
YouTubeHCPLive
1:02:43
Watch: Aprub - December 25, 2018
141 viewsDec 25, 2018
YouTubeNET25 News and Information
Aptevo Therapeutics: Aptevo Expands Differentiated CD3 Portfo…
9 months ago
finanznachrichten.de
0:12
Itepekimab & COPD: Phase 3 Trial Results Explained
129 views10 months ago
YouTubeMCQ Pedia
See more videos
Static thumbnail place holder